Frederic Oudea to become Sanofi's non-executive chairman
Reuters
Published Sep 05, 2022 04:24AM ET
PARIS (Reuters) - The appointment of Societe Generale (OTC:SCGLY)'s boss Frederic Oudea as non-executive chairman of Sanofi (NASDAQ:SNY) will be proposed at the next shareholders meeting of the French drugs group, Sanofi said on Monday.
Sanofi made the announcement in a statement appointing Oudea as "Censeur" (non-voting member) of the board with immediate effect.
"The appointment of Frederic Oudea as a director will be submitted for approval at the next Annual General Meeting," the ststement said.
"Following this shareholders' meeting, a proposal will be made to the board of directors of Sanofi to appoint Frederic Oudea as non-executive chairman of the board, replacing Serge Weinberg whose term of office will have expired, it said.
Oudea said in May he will leave his position as CEO and director of Societe Generale in May 2023.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.